Celldex Therapeutics, Inc. — Director's Dealing 2020

Jun 11, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2020-06-10

Reporting Person: Cavanaugh Sarah (SVP of Corp Affairs & Admin.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-10	Common Stock, par value $0.001 per share	P	1050	$4.83	Acquired	1367	Direct